Glucosuria and all-cause mortality among general screening participants.

about

Glucosuria and all-cause mortality among general screening participants.

Item

http://www.wikidata.org/entity/Q50057769

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Glucosuria and all-cause mortality among general screening participants.

@en

Glucosuria and all-cause mortality among general screening participants.

@nl

type

Item

label

Glucosuria and all-cause mortality among general screening participants.

@en

Glucosuria and all-cause mortality among general screening participants.

@nl

prefLabel

Glucosuria and all-cause mortality among general screening participants.

@en

Glucosuria and all-cause mortality among general screening participants.

@nl

P1476

Glucosuria and all-cause mortality among general screening participants.

@en

P2093

Chiho Iseki

http://www.w3.org/2001/XMLSchema#string

Ichiei Narita

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Tsuruya

http://www.w3.org/2001/XMLSchema#string

Koichi Asahi

http://www.w3.org/2001/XMLSchema#string

Kunihiro Yamagata

http://www.w3.org/2001/XMLSchema#string

Kunitoshi Iseki

http://www.w3.org/2001/XMLSchema#string

Masahide Kondo

http://www.w3.org/2001/XMLSchema#string

Masato Kasahara

http://www.w3.org/2001/XMLSchema#string

Shouichi Fujimoto

http://www.w3.org/2001/XMLSchema#string

Toshiki Moriyama

http://www.w3.org/2001/XMLSchema#string

P2860

Screening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force

Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting

Metrics for glycaemic control - from HbA1c to continuous glucose monitoring.

Diagnosis and classification of diabetes mellitus.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Budget impact analysis of chronic kidney disease mass screening test in Japan.

Activation of hypoxia-inducible factors prevents diabetic nephropathy.

Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.

Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial.

Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies

P2888

s10157-017-1528-0

P31

scholarly article

P356

10.1007/S10157-017-1528-0

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29330695

http://www.w3.org/2001/XMLSchema#string